To take the CE quiz, click here.
This quiz is open until February 2027.
Jane E. Sykes
BVSc (Hons), PhD, DACVIM
Dr. Sykes is a professor of small animal medicine and Chief Veterinary Medical Officer at the University of California, Davis, School of Veterinary Medicine, with a special interest in small animal infectious diseases. She obtained her veterinary degree and PhD in veterinary microbiology at the University of Melbourne in Australia and completed her residency at the University of Minnesota. She is a Diplomate of ACVIM. She is widely published in peer-reviewed journals and is the editor of the textbook Canine and Feline Infectious Diseases.
Read Articles Written by Jane E. SykesIn 2023, the American College of Veterinary Internal Medicine published an updated consensus statement on leptospirosis in dogs. This article provides an update on the diagnosis and management of leptospirosis, including new recommendations for annual vaccination of all dogs for leptospirosis—regardless of age, sex, breed, lifestyle, or geographic location—and refined handling precautions for dogs in which leptospirosis is suspected as a differential diagnosis.
Take-Home Points
- Leptospirosis is a serious multisystemic disease of dogs and humans caused by virulent strains of the spirochete bacteria Leptospira.
- Urinary shedding of pathogenic spirochetes by reservoir hosts contaminates the environment, creating a source of infection for new hosts.
- Although leptospirosis is most often manifested as acute kidney injury with or without evidence of cholestatic hepatopathy, other organs can be involved.
- All dogs can develop leptospirosis, and transmission can result from direct exposure to reservoir hosts.
- Because progression to acute kidney injury can occur within 24 to 48 hours, veterinarians should have a high index of suspicion for leptospirosis and consider early treatment.
- A combination of serologic and PCR tests may be needed for definitive diagnosis.
- Current 4-serovar leptospirosis vaccines are effective, have at least a 12-month duration of immunity, and have a safety profile similar to that of other common vaccines. Vaccination is recommended for all dogs.
- Sick dogs should be treated with 2 weeks of doxycycline or parenteral ampicillin. Early referral to a dialysis facility should be considered.
Leptospirosis is a globally important zoonotic disease caused by infection with pathogenic serovars of Leptospira spirochete bacteria. Although leptospirosis is widely known as a cause of acute kidney injury (AKI) and liver disease in dogs, affected dogs often have multisystemic illness. Despite the availability of effective vaccines, outbreaks in dogs continue to occur throughout the United States, even in more arid and urban regions.1,2 Worldwide, this disease is very common in tropical regions, where warm, humid conditions promote survival of the organism in the environment.
In 2023, the American College of Veterinary Internal Medicine (ACVIM) published an updated consensus statement on leptospirosis in dogs.3 This article provides an update on the diagnosis and management of leptospirosis, including recommendations from the 2023 ACVIM consensus statement.
Environmental Factors
Pathogenic Leptospira spirochetes circulate between the environment, reservoir hosts (especially rodents), and incidental hosts, which include dogs and humans. Reservoir hosts are subclinically infected animals that shed spirochetes continuously or intermittently from their renal tubules, where the organisms form a thick biofilm that shields them from immune detection and may be difficult to eliminate with antimicrobials.4 Many animal species can act as reservoir hosts, including mammals and poikilotherms, such as reptiles and amphibians5; however, the most important reservoir host species contributing to environmental contamination and disease are rodents, especially Norway rats (Rattus norvegicus). Globally, approximately 30% of Norway rats are infected with pathogenic leptospires; in tropical regions where resource-poor communities exist, up to 80% may be infected.6 Because reservoir hosts do not have clinical disease, they are not considered to have leptospirosis.3
Under suitable conditions, organisms shed into the environment by reservoir hosts can persist and serve as a source of infection for other reservoir hosts and incidental hosts. Optimal survival conditions for leptospires include humidity, temperatures between 0 °C and 30 °C (32 °F to 86 °F), and waterlogged soil; however, spirochetes can survive outside these conditions and can even survive freezing.7 Environmental survival is promoted by the formation of biofilm, which may explain the organism’s preference for waterlogged soil,8 as well as why outbreaks of leptospirosis are often delayed by several months after heavy rainfall or flooding. The seasonality of the disease varies depending on local climatic conditions, especially rainfall.9 In areas with year-round rainfall, leptospirosis may occur throughout the year.
With increased flooding associated with climate change and population growth, the incidence of leptospirosis in humans and animals is likely to increase.
Classification
Classification of pathogenic leptospires can be confusing; however, because there are more than 300 pathogenic serovars of Leptospira and current vaccines are serovar specific, knowledge of circulating organisms is important.
Pathogenic serovars are grouped into antigenically related serogroups based on their outer lipopolysaccharide antigens. This classification system means that multiple species of Leptospira can have the same serovar designation. For example, there is more than 1 serovar of Grippotyphosa (Leptospira interrogans serovar Grippotyphosa and Leptospira kirschneri serovar Grippotyphosa).10,11 Pathogenic leptospires are also grouped as P1 and P2 pathogens, with most disease in humans and animals caused by P1 pathogens, especially L interrogans and L kirschneri.10 Leptospires can also be classified as sequence types based on genome sequence information.
Although specific serovars and serogroups were previously associated with certain reservoir hosts (such as dogs and L interrogans serovar Canicola), it is increasingly apparent that organisms of the same serogroup can be harbored by multiple reservoir host species.12-14 Therefore, a specific reservoir host species cannot be assumed responsible for a leptospirosis outbreak associated with a specific serogroup. Regionally, sequence type associations may be more important.
Infection and Clinical Disease
Pathogenic leptospires penetrate abraded skin or mucous membranes. Dogs become infected through direct contact with infected urine, ingestion of infected tissues (e.g., predation of rodents or reptiles), or contact with contaminated water or soil.
Once in a host, leptospires multiply rapidly in the bloodstream and tissues. In response, some incidental hosts mount an inflammatory reaction that is responsible for the development of AKI or renal failure, hepatic injury, and vasculitis. Other organs that can be involved include the pancreas (pancreatitis), gastrointestinal tract (gastroenteritis), eye (uveitis), myocardium (cardiac arrhythmias), and lungs (leptospirosis pulmonary hemorrhage syndrome).3 Clinical manifestations may also depend on the age of the host, host genetic factors, the infectious dose, and the strain of Leptospira involved. Serologic surveys suggest that subclinical exposure is widespread and only a small percentage of dogs develop illness after infection.15
Clinical signs of leptospirosis typically become apparent 2 to 14 days after exposure.3 Pyrexia occurs early in the course of illness and may be rapidly (within 24 to 48 hours) followed by defervescence, with clinical signs of lethargy, anorexia, vomiting, diarrhea, dehydration, abdominal pain, and increased thirst and urination. Reluctance to move (due to myositis) and icterus may also be present. A small percentage of dogs may have ocular complications such as uveitis or petechial retinal hemorrhages.16 Respiratory distress may result from pulmonary hemorrhage, which can be associated with the development of anemia.17
Leptospirosis can occur in dogs as young as 11 weeks,18,19 in any dog breed, and regardless of geographic location and environment. Dogs in urban regions may be infected following exposure to rodent reservoir hosts, and outbreaks have been described in association with boarding or daycare environments.1 Over the past decade, diagnosis of leptospirosis in small-breed dogs has increased,20-23 possibly because this population of dogs may remain unvaccinated owing to concerns about adverse reactions to vaccination.
Leptospirosis has also been reported in cats, although they appear to be less susceptible to development of disease than dogs. Cats can act as reservoir hosts, although studies of infection in free-roaming cats have shown a wide variation in the prevalence of seroreactivity and kidney infection.24 In 1 study, only 10% of feral cats from northern California and Texas were seropositive, and no evidence of leptospiruria was detected using PCR assays.25
Laboratory Findings
In the first 24 to 48 hours of illness, results of a CBC and serum biochemistry panel may be normal or there may be evidence of mild neutrophilia and subtle electrolyte abnormalities. Subsequently, anemia, leukocytosis due to a neutrophilia with or without increased band neutrophils, monocytosis, lymphopenia, and thrombocytopenia may become apparent on a CBC.3 Serum biochemistry parameters that often emerge are azotemia, hyperphosphatemia, hypoalbuminemia, hyperbilirubinemia, and mild to moderately elevated activities of serum alanine transaminase and alkaline phosphatase. Although hyperkalemia has been reported, normokalemia or hypokalemia are more common due to the effect of Leptospira endotoxin on the renal medullary thick ascending limb tubular Na+-K+-ATPase.26
Hepatopathy is cholestatic, and evidence of liver failure (e.g., hypoglycemia, hypocholesterolemia, markedly increased liver enzyme activities) is not typically present. Hepatopathy in the absence of renal failure is rare but has been described in some cases.27
Urinalysis may reveal signs of tubular injury (e.g., isosthenuria, proteinuria, glucosuria, casts). The presence of glucosuria in the absence of hyperglycemia should always raise suspicion for leptospirosis, especially in unvaccinated dogs. Organisms are generally not visible in the urine sediment using routine light microscopy.
Imaging Findings
Thoracic radiography may reveal a focal, nodular, or diffuse interstitial to bronchointerstitial pattern; patterns may represent pulmonary hemorrhage.3 Occasionally, mild pleural effusion is evident. Because dogs may have radiographic evidence of pulmonary hemorrhage in the absence of respiratory signs, thoracic radiography is recommended for all dogs suspected to have leptospirosis; detection of abnormalities can help raise suspicion for a diagnosis of leptospirosis and guide judicious intravenous fluid therapy to prevent fluid overload with associated pulmonary edema.3
Hepatomegaly, splenomegaly, renomegaly, and/or peritoneal effusion may be evident from abdominal radiography. Hyperechoic renal cortices and mild renal pelvis dilation are occasionally seen with abdominal ultrasonography.3
Specific Diagnosis
Identification of leptospirosis requires a high degree of clinical suspicion for the disease based on knowledge of the range of possible clinical presentations. Although leptospirosis has occasionally been documented in dogs vaccinated with 4-serovar vaccines,28 affected dogs are more likely to be unvaccinated, years overdue for vaccination, or vaccinated with 2-serovar vaccines. Thus, other diagnoses are more likely in vaccinated dogs.
Because leptospirosis is an acute illness, the case definition developed by the ACVIM consensus panel for leptospirosis in dogs requires onset of illness within the past 2 weeks (TABLE 1).3 Dogs with signs such as chronic polyuria/polydipsia or chronic lethargy do not fall within the case definition and are not likely to have active infection with a pathogenic Leptospira species.
Currently available specific diagnostic tests for diagnosis of leptospirosis in North America include the microscopic agglutination test (MAT), in-clinic serologic assays that detect immunoglobulin G (IgG) (SNAP Lepto; IDEXX, idexx.com) or immunoglobulin M (IgM) (WITNESS Lepto; Zoetis, zoetisus.com), and nucleic acid amplification tests (usually PCR-based assays).3,29 Examination of urine specimens using darkfield microscopy can also be used for diagnosis, but this technique requires expertise and a darkfield microscope and lacks sensitivity. Growth of leptospires in culture requires expertise and special media and may require several weeks of incubation. Use of multiple types of media and inoculation of media patient-side may increase the chance of successful isolation, but culture is mostly used as a research tool.
Microscopic Agglutination Test
The reference standard test for diagnosis of leptospirosis is seroconversion using the MAT.29 In the MAT, serial twofold dilutions of patient serum are reacted with a battery of live pathogenic leptospiral serovars. The serum dilution that causes 50% of spirochetes to agglutinate using darkfield microscopy is reported to the clinician as the titer to the respective serovar tested. Multiple serovars are included to increase the chance of antibody detection to any single serovar. Most veterinary diagnostic laboratories that perform the MAT offer a panel of 6 or 7 different
serovars.30
The serovar with the highest titer is not necessarily the serovar causing infection. This is due to: (1) paradoxical serologic cross-reactivity, in which noninfecting serovars used in the panel are associated with higher titers than the infecting serovar; (2) the possibility that the infecting serovar is not in the panel, and all positive titers represent cross-reactions to noninfecting serovars; and (3) the possibility that even higher titers could be observed should another serovar be added to the panel.3
Decoding Vaccine Titers: A Literature-Based Review of Vaccine Titers in Companion Animal Practice
Titers are often negative in the first week of illness due to the short incubation period and delay in antibody production. Low-positive or negative titers after at least 1 week of illness make leptospirosis less likely. Positive titers early in the course of an illness may reflect previous subclinical infection (or vaccination for leptospirosis, should a vaccinated dog be tested) and are not diagnostic. Demonstration of a fourfold rise in titer is required over a 1- to 2-week interval.3 The results can also vary among laboratories; therefore, the same laboratory should be used for acute and convalescent testing.
In-Clinic Serologic Assays
In-clinic serologic assays yield qualitative (positive or negative) results and are useful for rapid assessment for the presence or absence of antibodies.31 Importantly, because these are antibody tests, a positive result does not imply infection and a negative result does not rule out infection. Should these kits yield negative results, the clinician should consider whether it may be too early for the animal to have developed antibodies (as can occur with the MAT). A second test can be performed 1 week later to see if the animal seroconverts.
The SNAP Lepto assay detects IgG; therefore, it may provide positive results in dogs with previous subclinical exposure or dogs that have been vaccinated for leptospirosis. For example, a leptospirosis-vaccinated dog with AKI secondary to ibuprofen toxicity may have a positive SNAP Lepto test result.
The WITNESS Lepto test detects IgM, and studies performed to date suggest that positive results with this assay strongly support a diagnosis of leptospirosis in dogs not recently vaccinated for leptospirosis with consistent clinical signs (specificity > 97%).32,33 Clinicians should consider reflex testing with the MAT to obtain a quantitative titer if positive results are obtained with in-clinic serologic tests, followed by convalescent serology 1 to 2 weeks later to document a change in titer.3
PCR Assays
Increasingly, PCR is being recognized as a promising tool for diagnosis of leptospirosis, especially in the first week of illness when antibody tests yield weak positive or negative results and antimicrobials have not yet been administered. However, sensitivity and specificity may vary geographically depending on the serovars present and their shedding patterns. Current assays may not detect some strains of Leptospira (such as those belonging to the P2 pathogens). Sensitivity may also be higher very early in the course of illness and in dogs that have not received any treatment with antimicrobials.
Because organisms are present in the blood in the first week of illness before appearing in the urine, both blood and urine specimens should be submitted to increase the chance of a positive result. Negative results do not rule out leptospirosis because organisms can be shed intermittently and in very low numbers. Positive results have been detected in the urine of some healthy dogs, especially those that are free-roaming, from kennels, or in shelters (acting as reservoir hosts).
Treatment
Left untreated, progression to irreversible renal failure can occur within days; therefore, treatment is indicated pending the results of specific diagnostic testing. Antimicrobials recommended for specific treatment of leptospirosis in dogs are intravenous penicillin derivatives or doxycycline. Doxycycline is the first choice, based on research using a hamster model of infection that showed doxycycline to be most effective for eliminating organisms from the renal tubules.34 However, other evidence to support this choice in dogs is lacking.
If parenteral doxycycline is not available or vomiting precludes administration of oral doxycycline, ampicillin is recommended (20 mg/kg IV q6h to q8h, adjusting dose down if severe azotemia is present) until vomiting has resolved.3 As soon as tolerated, a 2-week course of doxycycline (5 mg/kg PO q12h) should be administered, irrespective of the number of days the pet has previously received other antibiotics.
Supportive therapy is also indicated for organ dysfunction (e.g., IV fluids, proton pump inhibitors, antihypertensives, antiemetics, phosphate binders, packed red blood cells). Early enteral nutrition with a highly digestible, normal- to high-protein diet is indicated.3 In general, kidney diets are not appropriate for dogs with leptospirosis as they tend to be high in fat, which has the potential to exacerbate gastroenteritis or pancreatitis. If hydration has been properly addressed through fluid therapy and there is persistent anuria or oliguria, progressive azotemia, and evidence of overhydration, early referral for continuous renal replacement therapy may be the difference between complete recovery and death due to renal failure.3
Prevention
Because all dogs are at risk of leptospirosis—regardless of age, breed, sex, geographic location, lifestyle, or time of year—and because current 4-serovar vaccines have been shown to be safe and efficacious, the ACVIM consensus statement recommends that all dogs be vaccinated for leptospirosis.3 Because the duration of immunity for leptospirosis vaccines requires them to be administered annually, this represents a significant shift from current practices of vaccinating dogs every 3 years with core vaccines. Veterinarians should recommend that all dogs return for vaccination with leptospirosis vaccines annually; the distemper-adenovirus-parvovirus-parainfluenza (DAPP) combination vaccine should continue to be administered every 3 years according to guidelines from the AAHA and WSAVA.23,35 The ACVIM consensus panel also recommends that boarding and daycare environments require vaccination for leptospirosis and that vaccination protocols in shelters include leptospirosis vaccines.3
Historically, bacterin vaccines were associated with a higher rate of adverse effects than attenuated live vaccines; however, recent studies suggest that owing to new vaccine technology, currently available leptospirosis vaccines have an adverse effect profile similar to that of the DAPP combination vaccine, even in small-breed dogs.36 In North America, vaccines that contain serovars Canicola, Icterohaemorrhagiae, Pomona, and Grippotyphosa are in widespread use. The vaccines are generally safe and efficacious, and studies suggest they provide a minimum of 1 year of immunity.37-39 Vaccination of dogs with 4-serovar vaccines has been associated with reduction in the prevalence of disease in dogs worldwide,40 although disease can still occasionally occur in vaccinated dogs (usually caused by serovars that are not included in the vaccine).
Vaccination against pathogenic leptospires is strongly recommended even for small-breed dogs that live in urban areas as infection can follow direct or indirect exposure to rodents. Control of rodent exposure and minimizing access to livestock and wildlife can also prevent infection.
Public Health Risk
Leptospirosis represents a quintessential One Health problem due to the circulation of pathogenic spirochetes between the environment, reservoir hosts, and incidental hosts. Although most documented cases of human leptospirosis in North America result from recreational activities that involve water (rather than contact with diseased dogs), leptospirosis remains an important zoonosis. Rare reports of leptospirosis in humans following exposure to infected dogs exist,41 but unambiguous proof of transmission has been lacking, and prospective investigations of human disease in circumstances where exposure to diseased dogs is likely have failed to reveal any evidence of human infection or disease.42,43 Human leptospirosis is typically a “flu-like illness” but in some cases may be associated with vomiting, diarrhea, shock, jaundice, renal failure, pneumonia, meningitis, or abortion.
Any animal with acute renal failure should be treated as a suspected leptospirosis patient. Warnings should be placed on cages, gloves should be worn while handling presumably or definitively infected dogs, and a disinfectant should be used to clean areas soiled with urine. Owners should be warned that, without specific treatment, leptospires may be shed in the urine for months despite clinical recovery. Contact precautions can be lifted after 48 hours of specific antimicrobial therapy.3 One modeling study demonstrated that where populations of humans, rodents, and domestic/stray dogs intermingle, vaccination of dogs may reduce risk of human infection from rodents.44
Summary
Leptospirosis is a disease that threatens the health of companion dogs in both urban and rural areas worldwide. Pathogenic leptospires circulate between reservoir hosts, especially rodents, and the environment. Exposure of incidental hosts leads to multisystemic disease, especially manifested by evidence of AKI. Many different serovars, defined by their outer lipopolysaccharide antigens, can cause disease in dogs, and outbreaks continue to occur in dogs despite the widespread availability of effective vaccines. Recent outbreaks have been associated with boarding kennel environments. Diagnosis of leptospirosis relies on use of a combination of PCR and acute and convalescent serologic testing. Current vaccines provide serovar-specific protection; however, leptospirosis is rarely reported in dogs that have been vaccinated with 4-serovar vaccines. Because all dogs are at risk of leptospirosis—regardless of age, breed, sex, geographic location, lifestyle, or time of year—and because current 4-serovar vaccines have been shown to be safe and efficacious, it is recommended that all dogs be vaccinated annually for leptospirosis.
References
1. Los Angeles County Department of Public Health. Leptospirosis in dogs in Los Angeles County in 2021. Updated March 11, 2022. Accessed October 9, 2024. http://www.publichealth.lacounty.gov/vet/Leptospirosis2021.htm
2. Wyoming Department of Health. Rare bacterial infections reported in Wyoming. September 15, 2023. Accessed October 9, 2024. https://health.wyo.gov/rare-bacterial-infections-reported-in-wyoming
3. Sykes JE, Francey T, Schuller S, Stoddard RA, Cowgill LD, Moore GE. Updated ACVIM consensus statement on leptospirosis in dogs. J Vet Intern Med. 2023;37(6);1966-1982. doi:10.1111/jvim.16903
4. Santos AAN, Ribeiro PDS, da Franca GV, et al. Leptospira interrogans biofilm formation in Rattus norvegicus (Norway rats) natural reservoirs. PLoS Negl Trop Dis. 2021;15(9):e0009736. doi:10.1371/journal.pntd.0009736
5. Ko AI, Goarant C, Picardeau M. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol. 2009;7(10):736-747. doi:10.1038/nrmicro2208
6. Boey K, Shiokawa K, Rajeev S. Leptospira infection in rats: a literature review of global prevalence and distribution. PLoS Negl Trop Dis. 2019;13(8):e0007499. doi:10.1371/journal.pntd.0007499
7. Bradley EA, Lockaby G. Leptospirosis and the environment: a review and future directions. Pathogens. 2023;12(9):1167. doi:10.3390/pathogens12091167
8. Yanagihara Y, Villanueva SYAM, Nomura N, et al. Leptospira is an environmental bacterium that grows in waterlogged soil. Microbiol Spectr. 2022;10(2):e0215721. doi:10.1128/spectrum.02157-21
9. Lee HS, Levine M, Guptill-Yoran C, Johnson AJ, von Kamecke P, Moore GE. Regional and temporal variations of Leptospira seropositivity in dogs in the United States, 2000-2010. J Vet Intern Med. 2014;28(3):779-788. doi:10.1111/jvim.12335
10. Vincent AT, Schiettekatte O, Goarant C, et al. Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics. PLoS Negl Trop Dis. 2019;13(5):e0007270. doi:10.1371/journal.pntd.0007270
11. Sykes JE, Gamage CD, Haake DA, Nally JE. Understanding leptospirosis: application of state-of-the-art molecular typing tools with a One Health lens. Am J Vet Res. 2022;83(10):ajvr.22.06.0104. doi:10.2460/ajvr.22.06.0104
12. Grillová L, Angermeier H, Levy M, Giard M, Lastère S, Picardeau M. Circulating genotypes of Leptospira in French Polynesia: an 9-year molecular epidemiology surveillance follow-up study. PLoS Negl Trop Dis. 2020;14(9):e0008662. doi:10.1371/journal.pntd.0008662
13. Meny P, Iglesias T, Menéndez C, et al. Seroprevalence of anti-Leptospira antibodies in equines and associated workers-Isolation of Leptospira interrogans serogroup Canicola from equine urine. Zoonoses Public Health. 2022;69(5):526-536. doi:10.1111/zph.12942
14. Rahelinirina S, Léon A, Harstskeerl RA, et al. First isolation and direct evidence for the existence of large small-mammal reservoirs of Leptospira sp. in Madagascar. PloS One. 2010;5(11):e14111. doi:10.1371/journal.pone.0014111
15. Ricardo T, Azócar-Aedo LI, Previtali MA, Monti G. Seroprevalence of pathogenic Leptospira serogroups in asymptomatic domestic dogs and cats: systematic review and meta-analysis. Front Vet Sci. 2024;11:1301959. doi:10.3389/fvets.2024.1301959
16. Violette NP, Ledbetter EC. Punctate retinal hemorrhage and its relation to ocular and systemic disease in dogs: 83 cases. Vet Ophthalmol. 2018;21(3):233-239. doi:10.1111/vop.12496
17. Klopfleisch R, Kohn B, Plog S, et al. An emerging pulmonary haemorrhagic syndrome in dogs: similar to the human leptospiral pulmonary haemorrhagic syndrome? Vet Med Int. 2010;2010:928541. doi:10.4061/2010/928541
18. Rubanick JV, Fries RC, Waugh CE, Pashmakova MB. Severe hyperkalemia presenting with wide-complex tachycardia in a puppy with acute kidney injury secondary to leptospirosis. J Vet Emerg Crit Care (San Antonio). 2016;26(6):858-863. doi:10.1111/vec.12454
19. Muller C, Gaguère E, Muller A, Husson JC, Degorce-Rubiales F. Localized cutaneous calcinosis associated with leptospirosis in a 4-month-old beagle puppy. Can Vet J. 2022;63(10):1027-1031.
20. Stull JW, Evason M, Weese JS, Yu J, Szlosek D, Smith AM. Canine leptospirosis in Canada, test-positive proportion and risk factors (2009 to 2018): a cross-sectional study. PloS One. 2022;17(6):e0270313. doi:10.1371/journal.pone.0270313
21. Smith AM, Stull JW, Moore GE. Potential drivers for the re-emergence of canine leptospirosis in the United States and Canada. Trop Med Infect Dis. 2022;7(11):377. doi:10.3390/tropicalmed7110377
22. Alton GD, Berke O, Reid-Smith R, Ojkic D, Prescott JF. Increase in seroprevalence of canine leptospirosis and its risk factors, Ontario 1998-2006. Can J Vet Res. 2009;73(3):167-175.
23. Francey T, Schweighauser A, Reber A, Schuller S. Evaluation of changes in the epidemiology of leptospirosis in dogs after introduction of a quadrivalent antileptospiral vaccine in a highly endemic area. J Vet Intern Med. 2020;34(6):2405-2417. doi:10.1111/jvim.15947
24. Murillo A, Goris M, Ahmed A, Cuenca R, Pastor J. Leptospirosis in cats: current literature review to guide diagnosis and management. J Feline Med Surg. 2020;22(3):216-228. doi:10.1177/1098612X20903601
25. Sebastian JF, Reagan KL, Peavy T, Zecca IB, Hamer SA, Sykes JE. Evaluation of Leptospira infection and exposure in free-roaming cat populations in northern California and southern Texas. J Feline Med Surg. 2023;25(3):1098612X231162471. doi:10.1177/1098612X231162471
26. Burth P, Younes-Ibrahim M, Gonçalez FH, Costa ER, Faria MV. Purification and characterization of a Na+, K+ ATPase inhibitor found in an endotoxin of Leptospira interrogans. Infect Immun. 1997;65(4):1557-1560. https://doi.org/10.1128/iai.65.4.1557-1560.1997
27. Rahman MSA, Khor KH, Khairani-Bejo S, Lau SF, Mazlan M, Roslan MA. Risk and predictive factors of leptospirosis in dogs diagnosed with kidney and/or liver disease in Selangor, Malaysia. Animals (Basel). 2021;11(12):3405. doi:10.3390/ani11123405
28. Bertasio C, Boniotti MB, Lucchese L, et al. Detection of new Leptospira genotypes infecting symptomatic dogs: is a new vaccine formulation needed? Pathogens. 2020;9(6):484. doi:10.3390/pathogens9060484
29. Sykes JE, Reagan KL, Nally JE, Galloway RL, Haake DA. Role of diagnostics in epidemiology, management, surveillance, and control of leptospirosis. Pathogens. 2022;11(4):395. doi:10.3390/pathogens11040395
30. Goris MGA, Hartskeerl RA. Leptospirosis serodiagnosis by the microscopic agglutination test. Curr Protoc Microbiol. 2014;32:Unit 12E.5. doi:10.1002/9780471729259.mc12e05s32
31. Lizer J, Velineni S, Weber A, Krecic M, Meeus P. Evaluation of 3 serological tests for early detection of Leptospira-specific antibodies in experimentally infected dogs. J Vet Intern Med. 2018;32(1):201-207. doi:10.1111/jvim.14865
32. Lizer J, Grahlmann M, Hapke H, Velineni S, Lin D, Kohn B. Evaluation of a rapid IgM detection test for diagnosis of acute leptospirosis in dogs. Vet Rec. 2017;180(21):517. doi:10.1136/vr.104134
33. Troìa R, Balboni A, Zamagni S, et al. Prospective evaluation of rapid point-of-care tests for the diagnosis of acute leptospirosis in dogs. Vet J. 2018;237:37-42. doi:10.1016/j.tvjl.2018.05.010
34. Truccolo J, Charavay F, Merien F, Perolat P. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother. 2002;46(3):848-853. doi:10.1128/AAC.46.3.848-853.2002
35. Squires RA, Crawford C, Marcondes M, Whitley N. 2024 Guidelines for the vaccination of dogs and cats—compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). J Small Anim Pract. 2024;65(5):277-316. doi:10.1111/jsap.13718
36. Moore GE, Morrison J, Saito EK, Spofford N, Yang M. Breed, smaller weight, and multiple injections are associated with increased adverse event reports within three days following canine vaccine administration. JAVMA. 2023;261(11):1653-1659. doi:10.2460/javma.23.03.0181
37. Wilson S, Stirling C, Thomas A, et al. Duration of immunity of a multivalent (DHPPi/L4R) canine vaccine against four Leptospira serovars. Vaccine. 2013;31(31):3126-3130. doi:10.1016/j.vaccine.2013.05.043
38. Grosenbaugh DA, Pardo MC. Fifteen-month duration of immunity for the serovar Grippotyphosa fraction of a tetravalent canine leptospirosis vaccine. Vet Rec. 2018;182(23):665. doi:10.1136/vr.104694
39. Minke JM, Bey R, Tronel JP, et al. Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bi-valent inactivated leptospirosis vaccine. Vet Microbiol. 2009;137(1-2):137-145. doi:10.1016/j.vetmic.2008.12.021
40. Bergmann Esteves S, Moreira Santos C, Ferreira Salgado F, et al. Efficacy of commercially available vaccines against canine leptospirosis: A systematic review and meta-analysis. Vaccine. 2022;40(12):1722-1740. doi:10.1016/j.vaccine.2022.02.021
41. International Leptospirosis Society. Proficiency testing scheme for the leptospirosis MAT. Accessed October 9, 2024. http://leptosociety.org/proficiency_testing
42. Guagliardo SAJ, Iverson SA, Reynolds L, et al. Despite high-risk exposures, no evidence of zoonotic transmission during a canine outbreak of leptospirosis. Zoonoses Public Health. 2019;66(2):223-231. doi:10.1111/zph.12557
43. Mazzotta E, Lucchese L, Salata C, et al. Are small animal practitioners occupationally exposed to leptospirosis? Results of a serological survey. Int J Environ Res Public Health. 2022;19(3):1797. doi:10.3390/ijerph19031797
44. Belsare AV, Gompper ME, Mason M, Munoz-Zanzi C. Investigating Leptospira dynamics in a multi-host community using an agent-based modelling approach. Transbound Emerg Dis. 2022;69(6):3780-3789. doi:10.1111/tbed.14750
CE Quiz
This article has been submitted for RACE approval for 1 hour of continuing education credit and will be opened for enrollment upon approval. To receive credit, take the test at vetfolio.com. Free registration is required. Questions and answers online may differ from those below. Tests are valid for 2 years from the date of approval.
1. Which of the following reservoir hosts is considered the most important for maintenance of pathogenic leptospires worldwide?
a. Cattle
b. Dogs
c. Rats
d. Mice
e. Horses
2. Which antimicrobial treatment approach is preferred (if tolerated) for sick dogs with leptospirosis?
a. Ampicillin 22 mg/kg IV q6h, transitioning to oral doxycycline for 2 weeks when vomiting stops
b. Doxycycline 5 mg/kg IV or PO q12h for a total of 2 weeks
c. Doxycycline 5 mg/kg IV or PO q12h for 4 weeks
d. Enrofloxacin 5 mg/kg IV or PO q24h for 2 weeks
e. Clindamycin 10 mg/kg IV q8h, transitioning to oral doxycycline for 2 weeks when vomiting stops
3. Which of the following statements about vaccination for leptospirosis is false?
a. Newer leptospirosis vaccines provide protection regardless of the identity of circulating serovars.
b. All dogs should be vaccinated annually for leptospirosis, regardless of age, breed, sex, lifestyle, or geographic location.
c. Leptospirosis vaccination should be commenced in puppies as soon as label recommendations permit.
d. Current leptospirosis vaccination should be required for boarding/daycare admission.
e. Current leptospirosis vaccines appear to protect dogs from disease and have adverse reaction rates similar to those of distemper-adenovirus-parvovirus-parainfluenza vaccines.
4. Which of the following clinical findings, when present in association with biochemical evidence of acute kidney injury, should raise suspicion for leptospirosis?
a. Thrombocytopenia
b. Ultrasonographic evidence of pancreatitis
c. Glucosuria in the absence of hyperglycemia
d. Increased activity of serum creatine kinase
e. Any of the above
5. For how long should contact handling precautions be adhered to in a dog with suspected leptospirosis?
a. Until an alternative diagnosis has been identified or leptospirosis has been ruled out
b. Until appropriate antimicrobials have been administered for 48 hours
c. Until appropriate antimicrobials have been administered for 72 hours
d. Precautions are no longer recommended because dogs with leptospirosis are unlikely to transmit infection to humans